O Berk pharma bottle is ready to ship

Published: 27-May-2010

HDPE Pharma Oblong in amber now available from stock

O Berk Company, a US supplier and distributor of glass and plastic containers, closures, pumps and sprayers for the pharmaceutical and healthcare industries, is offering its 16oz HDPE Pharma Oblong bottle in amber from stock. The bottle is also available by special order in natural, white or a custom colour.

The 16oz Pharma Oblong is suitable for prescription and over-the-counter (OTC) liquid pharmaceutical products. There bottle is supplied with a variety of child-resistant and standard continuous threaded closures. The bottle surface has an indented panel that is easy to personalise.

Both bottles and closures are supported with data indicating US FDA compliance.

See more

You may also like

Research & Development

Quotient Sciences extends partnership for ultra-rare disease treatment

Read more
This collaboration reinforces Quotient Sciences’ commitment to supporting the manufacture of niche and smaller volume commercial products often overlooked by larger CDMOs

Trending Articles

  1. Destination Russia for new NYK Logistics warehouse <p>Logistics specialist NYK is expanding its market presence with the launch of new warehousing operation in Moscow, Russia.</p>
  2. Echo MS+ integration enhances high-throughput mass spectrometry SCIEX expands compatibility with the ZenoTOF 8600 system to deliver greater sensitivity and automation capabilities
  3. Drug-loaded pellets: unlocking flexible oral dosage design with modern pelletisation technologies Produced using advanced extrusion–spheronisation technologies such as GEA’s NICA systems, drug-loaded pellets are gaining traction as a flexible and scalable oral solid dosage platform that enhances release control, patient outcomes and manufacturing efficiency
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    Automated visual inspection: reducing false rejects with intelligent bubble masking This article explores how intelligent bubble masking in automated visual inspection systems can significantly reduce false rejects in biopharmaceutical manufacturing by accurately distinguishing harmless bubbles from harmful particles
  5. DHL Group expands dedicated Airfreight Cold Chain Network to strengthen global health logistics DHL Group has expanded its Airfreight Cold Chain Network and introduced a newly branded Boeing 777 freighter to enhance temperature-controlled transport capacity

Upcoming event

DCAT Week

23–26 March 2026 | Conference | New York, US See all

You may also like

Research & Development

Quotient Sciences extends partnership for ultra-rare disease treatment

This collaboration reinforces Quotient Sciences’ commitment to supporting the manufacture of niche and smaller volume commercial products often overlooked by larger CDMOs
Research & Development

OSE Immunotherapeutics receives positive IDMC review for Phase III ARTEMIA trial

OSE Immunotherapeutics SA has received a second positive recommendation from the Independent Data Monitoring Committee to continue its Phase III ARTEMIA trial of Tedopi in advanced non-small cell lung cancer
Research & Development

Vilnius University scientists reveal new role for CRISPR-Cas9 in bacterial immunity

The researchers report in Molecular Cell that the CRISPR-Cas9 protein plays a previously unknown role in selecting and integrating viral DNA fragments during bacterial immune memory formation
Research & Development

Lilly’s Orforglipron beats oral semaglutide in Phase III ACHIEVE-3 trial with superior weight loss

Head-to-head data published in The Lancet show Eli Lilly's oral GLP-1 candidate orforglipron delivered significantly greater HbA1c reductions and weight loss than oral semaglutide in adults with type 2 diabetes, supporting global regulatory submissions
Manufacturing

Viatris to cut 10% of its global workforce after Indian plant fire

Viatris has lowered its profit outlook for 2026 after a fire in February shut down a key plant in Nashik, India. Despite this, the company reported stronger-than-expected revenue and announced a restructuring plan
Regulatory

CStone's sugemalimab approved by MHRA for Stage III NSCLC

The MHRA's decision marks the biopharma's second indication approved for the product in the UK, with a global commercial rollout for sugemalimab now actively underway
Manufacturing

GEA opens new technology centre in Germany

The opening of the new technology centre for pharmaceutical freeze-drying systems will strengthen the supplier's position in the growing pharmaceutical applications market
Subscribe now